Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-12-10
著者
-
Ishiwata Isamu
Ishiwata Obstetrics and Gynecology Hospital
-
Ishiwata Isamu
聖マリアンナ医科大学 医学部産婦人科
-
Ishiwata Isamu
Ishiwata Gynecologic Hospital
-
Ishiwata Isamu
石渡産婦人科病院
-
Ishiwata Isamu
東海大学 医学部病理診断学
-
Kita Tsunekazu
Department of Obstetrics and Gynecology, Teikyo University School of Medicine
-
ISHIZUKA Bunpei
Department of Obstetrics and Gynecology, Saint Marianna University School of Medicine
-
Tanaka Kyoko
Department Of Obstetrics And Gynecology School Of Medicine Keio University
-
Suzuki Nao
Department Of Obstetrics And Gynecology School Of Medicine Keio University
-
Suzuki Nao
Department Of Obstetrics And Gynecology St. Marianna University School Of Medicine
-
Suzuki Nao
Department Of General Dentistry Fukuoka Dental College
-
IWAMORI Masao
Department of Biochemistry,Faculty of Medicine,University of Tokyo
-
KIGUCHI Kazushige
Department of Obstetrics and Gynecology, School of Medicine, Keio University
-
KOBAYASHI Yoichi
Department of Operative Dentistry, Hokkaido University School of Dentistry
-
IWAMORI Yuriko
Department of Biochemistry, Faculty of Science and Technology, Kinki University
-
Ishizuka Bunpei
Department Of Obstetrics And Gynecology St. Marianna University School Of Medicine
-
Ishizuka B
Dept. Gynecol St. Mariannna Univ. Sch. Med
-
Ishizuka Bunpei
Department Of Ob/gyn St. Marianna University School Of Medicine
-
Kiguchi Kazushige
G Hosp
-
Tsukazaki Katsumi
Department Of Obstetrics And Genecology National Defense Medical College
-
Iwamori Masao
Department Of Biochemistry Faculty Of Medicine University Of Tokyo
-
Ishiwata I
Ishiwata Gynecologic Hospital
-
Iwamori Y
Department Of Biochemistry Faculty Of Science And Technology Kinki University
-
Iwamori Yuriko
Department Of Biochemistry Faculty Of Science And Technology Kinki University
-
Kita Tsunekazu
Department Of Obstetrics And Gynecology National Defense Medical College
-
KIKUCHI Yoshihiro
Ohki-Memorial Kikuchi Cancer Center for Women
-
Ishiwata Isamu
Institute Of Cell Biology Ishiwata Obstetrics And Gynecological Hospital
-
Kiguchi K
Department Of Obstetrics And Gynecology St. Marianna University School Of Medicine
-
Iwamori Masao
Kinki Univ. Osaka
-
Kobayashi Yoichi
Department Of Obstetrics And Gynecology St. Marianna University School Of Medicine
-
Kobayashi Yoichi
Department Of Chemistry School Of Science And Technology Kwansei Gakuin University
-
Kiguchi Kazushige
Department Of Obstetrics And Gynecology Tokyo Hospital St. Marianna University School Of Medicine
-
Kiguchi Kazushige
Department Of Obstetrics And Gynecology School Of Medicine Keio University
-
Kita Tsunekazu
Department Of Obstetrics And Gynecology Natinal Dfense Medical College
-
Kita Tsunekazu
Department Of Obstetrics And Gynecology Nara Prefectural Nara Hospital
-
SUZUKI Nao
Department of Obstetrics and Gynecology, St. Marianna University School of Medicine
関連論文
- P1-182 機能的スクリーニングを用いたDNA過剰メチル化により発現抑制される子宮体癌新規癌抑制型microRNAの探索(Group23 子宮体部悪性腫瘍1,一般演題,第62回日本産科婦人科学会学術講演会)
- P2-203 再発子宮体癌症例に対するPlatinum free intervalに基づいた治療戦略の検証(Group68 子宮体部悪性腫瘍5,一般演題,第62回日本産科婦人科学会学術講演会)
- Y-12 sentinel navigation system(SNS)を用いて微小転移リンパ節を確認し得た子宮体癌4症例(婦人科腫瘍,優秀演題賞候補プログラム,第62回日本産科婦人科学会学術講演会)
- P3-15 子宮体癌術後例における血清脂質値の特徴(Group99 更年期・老年期2,一般演題,第62回日本産科婦人科学会学術講演会)
- P1-217 腫瘍間質の遺伝子発現解析による進行上皮性卵巣癌の予後規定因子の同定(Group26 卵巣腫瘍2,一般演題,第62回日本産科婦人科学会学術講演会)
- P1-213 GNAS遺伝子の増幅は標準治療を施行した上皮性卵巣癌の独立した予後因子である(Group26 卵巣腫瘍2,一般演題,第62回日本産科婦人科学会学術講演会)
- PII-15 子宮体癌におけるTリンパ球浸潤と臨床病理学的因子の検討(生殖器,ポスター2,第50回日本組織細胞化学会総会・学術集会)
- K3-45 標準治療を受けた表層上皮性卵巣癌の再発リスクを規程する遺伝子の探索(高得点演題16 腫瘍,高得点演題プログラム,第61回日本産科婦人科学会学術講演会)
- K3-46 若年体癌症例に対する子宮温存目的酢酸メドロキシプロゲステロン(MPA)療法のpitfall : 子宮摘出に至った21症例における子宮外病変の検討より(高得点演題16 腫瘍,高得点演題プログラム,第61回日本産科婦人科学会学術講演会)
- K1-42 UGT1A1遺伝子多型とイリノテカンの有害事象およびグルクロン酸抱合能に関するゲノム薬理学的検討(高得点演題7 腫瘍,高得点演題プログラム,第61回日本産科婦人科学会学術講演会)
- AP-23 卵巣境界悪性腫瘍における腹腔細胞診疑陽性症例の検討(卵巣・その他の女***2,グローバル時代の細胞診,第47回日本臨床細胞学会秋期大会)
- P2-251 子宮癌肉腫と子宮内膜癌の臨床的相違に関する検討(Group74 子宮体部悪性腫瘍6,一般演題,第62回日本産科婦人科学会学術講演会)
- P1-183 子宮体癌培養細胞株を用いたエピジェネティックに制御され癌抑制遺伝子として機能するmicroRNAの検索(Group23 子宮体部悪性腫瘍1,一般演題,第62回日本産科婦人科学会学術講演会)
- 子宮体癌に対する化学療法
- 分子標的薬を用いた治験の実際 : 当院における医師主導治験実施体制の整備を中心に
- P4-99 若年子宮体癌の高容量黄体ホルモン療法の治療終了時期判定に有用な2色FISH法(Group105 子宮体部悪性腫瘍7,一般演題,第60回日本産科婦人科学会学術講演会)
- P2-229 遺伝性乳癌卵巣癌の可能性がある受診者を対象としたBRCA1およびBRCA2遺伝子解析(Group60 卵巣腫瘍6,一般演題,第60回日本産科婦人科学会学術講演会)
- P1-132 子宮体癌高転移細胞株の細胞表面糖鎖および分子発現解析(Group15 子宮体部悪性腫瘍1,一般演題,第60回日本産科婦人科学会学術講演会)
- PII-16 子宮体癌における腹腔細胞診の臨床的意義と新規診断マーカーの検索(生殖器,ポスター2,第50回日本組織細胞化学会総会・学術集会)
- P-127 子宮頸部大細胞神経内分泌癌の一例(子宮頸部(8),グローバル時代の細胞診,第47回日本臨床細胞学会秋期大会)
- S2-4 子宮体癌における腹腔細胞診の意義(腹腔内細胞診,細胞学・基礎と臨床の架け橋,第49回日本臨床細胞学会総会(春期大会))
- K4-3 塩酸イリノテカンの副作用軽減を目指したUGTIA1遺伝子多型解析(高得点婦人科腫瘍学7,高得点演題プログラム,第60回日本産科婦人科学会学術講演会)
- P2-39 Aurora-A siRNAはin vivoにおける子宮体癌細胞に対するタキサン製剤の抗腫瘍効果を増強する(Group38 子宮体部悪性腫瘍6,一般演題,第61回日本産科婦人科学会学術講演会)
- P3-20 子宮頸癌細胞におけるWRN遺伝子異常メチル化と抗癌剤感受性との関連(Group78 子宮頸部悪性腫瘍9,一般演題,第61回日本産科婦人科学会学術講演会)
- P4-92 子宮体癌における分裂期キナーゼAurora-Aの発現と抗癌剤感受性との関連(Group104 子宮体部悪性腫瘍6,一般演題,第60回日本産科婦人科学会学術講演会)
- P3-188 NBI(Narrow Band Imaging)システムを用いた軟性子宮鏡による子宮内膜病変の診断への応用(Group122 子宮体部悪性腫瘍10,一般演題,第62回日本産科婦人科学会学術講演会)
- An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression : Its Application for Refractory Ovarian Cancer
- An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression : Its Application for Refractory Ovarian Cancer
- 子宮内膜病変診断法としての2色FISH法の治療への応用 : 若年子宮体癌に対する妊孕性温存療法治療終了時期判定(F.病理診断)
- 卵巣癌初回治療後の再発サーベイランス方法の構築 : ガイドライン作成のためのエビデンス作りを目指して
- 腹式広汎性子宮頸部摘出術
- 子宮傍結合織炎 (子宮疾患・子宮内膜症の臨床--基礎・臨床研究のアップデート) -- (感染症・炎症性疾患)
- 子宮体癌の術後化学療法--タキサンとプラチナの併用に関する新たなエビデンスの構築を目指して (特集 婦人科がん治療の臨床試験--新たなエビデンスを求めて)
- IS-36 Two cases of complete remission of metastatic and relapsed uterine cervical carcinoma using weekly administration of bevacizumab and paclitaxel/carboplatin(Group4 Oncology2,International Session)
- IS-33 Experience of combination therapy with Bevacizumab for recurrent/refractory clear cell carcinoma of the ovary(Group4 Oncology2,International Session)
- Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma
- Clinical significance of first-line chemotherapy and complete surgical staging for clear cell adenocarcinoma of the ovary(Oncology 3)
- PDZK1 is a potential target for 1q21-q22 amplification frequently detected in drug resistant ovarian cancer(Oncology 1)
- 4-13.CGH and cDNA micoarray analysis of drug resistance in gynecologic malignancy(Session 6 Oncology 6)
- Inhibitory Effects of Ginsenoside Rh_2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells
- Growth-inhibitory Effects of N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HC1 Combined with Cisplatin on Human Ovarian Cancer Cells Inoculated into Nude Mice
- Altered Expression of γ-Glutamylcysteine Synthetase, Metallothionein and Topoisomerase I or II during Acquisition of Drug Resistance to Cisplatin in Human Ovarian Cancer Cells
- Serum carbohydrate antigen elevations in endometrial adenocarcinomas : Characterization of DU-PAN-2 expression as a tumor marker
- 子宮体癌は増えている (今月の臨床 子宮体癌診療の動向?これだけは知っておきたい)
- Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary
- A case of pulmonary type of ovarian small cell carcinoma
- IIB-01 Expression of Hypoxia-related markers, GLUT-1 and HIF-1 alpha, in the ovarian tumors : association with histology and tumor grade(THE 46TH ANNUAL MEETING OF THE JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY)
- HYPERPLASIA OF BROWN ADIPOSE TISSUE AFTER CHRONIC STIMULATION OF β3-ADRENERGIC RECEPTOR IN RATS
- WS3-1 Application of two-color FISH with liquid-based thin-layer cytological preparations for uterine cancers
- P-22 Detection of chromosomal alterations in ovarian cancers using double-targeted FISH
- Chondrosarcomatous differentiation in metastatic deposit of serous papillary cystadenocarcinoma
- Differentially Regulated Genes as Putative Targets of Amplifications at 20q in Ovarian Cancers
- P1-IS-5 Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia
- Significance of MUC1 mucin expression in clear cell adenocarcinoma of the ovary
- P-IS-27 Establishment and characterization of two human malignant mesothelioma cell lines (HMMME and HMMMF) from the same patient(Oncology 7,Group 94,International Session)
- 6 Cell-Biological Properties of Normal Uterine Cervical Epithelia of Transformation Zone in Vitro and Establishment of the Immortalized Cell Line
- 2 Human Papillomavirus Types 56 and 59 in Novel Cervical Cancer Cell Lines
- IS-28 Embryogenesis and organogenesis of mouse embryos in in vitro culture
- CHANGE IN LEUKOCYTE COUNT IN PERIPHERAL BLOOD OF NUDE MOUSE BEARING TRANSPLANTED GYNECOLOGICAL MALIGNANT TUMORS
- GLANDULAR CELL PROPERTIES OF CELL LINE (HKUS) DERIVED FROM SMALL CELL NON-KERATINIZING SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX
- BIOLOGICAL CHARACTERISTICS OF HUMAN UTERINE LEIOMYOSARCOMA CELL LINE, PARTICULARLY ITS HETEROTRANSPLANTABILITY AND EFFECT ON PROLIFERATION OF VASCULAR ENDOTHELIAL CELLS
- CHARACTERIZATION OF NEWLY ESTABLISHED CELL LINE HUOA FROM A HUMAN OVARIAN SEROUS CYSTADENOCARCINOMA
- ACTIVITY OF TUMOR ANGIOGENESIS FACTOR OBTAINED FROM OVARIAN CARCINOMA CELL LINE AND ITS PURIFICATION
- 43.Cytodiagnosis of uterine leiomyosarcomas and carcinosarcoma through specific stainings and electron microscopy in smear cells : 2nd report(D群 子宮体部, 示説展示, 第19回日本臨床細胞学会秋期大会記事)
- Chronic administration of β-Adrenergic Agonists Can Mimic the Stimulative Effect of Cold Exposure on Protei Synthesis in Rat Brown adipose Tissue
- Subcellular Localization of Galactosyltransferase Associated with Tumors in Endometrial and Ovarian Cancer Cells
- A-7 The expression of β1,4-galactosyltransferase in human trophoblasts
- Effect of Gelonin Immunoconjugate with Monoclonal Antibody MSN-1 to Endometrial Adenocarcinoma on Antigen-producing Tumor Cells in vivo
- Current Situation of the Cervical Cancer Screening System in Japan and Proposal for the Future
- MELATONIN SYNTHESIS IN THE OVARY AND EFFECT OF MELATONIN ON IN VITRO FERTILIZATION AND EMBRYO DEVELOPMENT
- 2-12.Clinical prospective study on post-surgical bladder dysfunction at radical hysterectomy in aspect of histological analysis of pelvic nerve innervations.(Session 3 Oncology 3)
- ANTITUMOR EFFICACY OF RECOMBINANT INTERLEUKIN 2-ACTIVATED KILLER CELLS AGAINST ENDOMETRIAL CANCERS
- Characteristic Expression of Lewis-antigenic Glycolipids in Human Ovarian Carcinoma-derived Cells with Anticancer Drug-resistance
- Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the α1, 2-fucosyltransferase gene
- Therapeutic strategy targeting the mTOR-HIF-1α-VEGF pathway in ovarian clear cell adenocarcinoma
- Apoptosis of Human Embryonal Carcinoma Cells with in vitro Differentiation
- A survey of patients with menopausal symptoms on Complementary and Alternative Medicine (CAM) at the St. Marianna University Hospital
- Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer
- Ovarian toxicity of paclitaxel and effect on fertility in the rat
- Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance
- P2-14-25 エピゲノム異常により発現抑制され細胞増殖抑制活性を有する子宮体がん関連microRNA及びその標的分子の同定(Group98 子宮体部悪性腫瘍・基礎2,一般演題,第63回日本産科婦人科学会学術講演会)
- K-13 若年子宮体癌132例に対する妊孕性温存療法の長期予後解析結果 : 分娩後再発を中心に(高得点演題3 腫瘍,第63回日本産科婦人科学会学術講演会)
- P2-17-9 Lower uterine segment(LUS)から発生する子宮体癌とLynch症候群との関連(Group104 子宮体部悪性腫瘍・診断・手術3,一般演題,第63回日本産科婦人科学会学術講演会)
- Selectiv Expansion of Human Natural Killer Cells from Peripheral Blood Mononuclear Cells by the Cell Line, WFWT
- CA-125 LEVELS IN THE CONDITIONED MEDIA OF THE GYNECOLOGICAL TUMOR CELL LINES
- Estrogen sulfotransferase and sulfatase : Roles in the regulation of estrogen activity in human uterine endometrial carcinomas
- Expression of Glycolipids Bearing Lewis Phenotypes in Tissues and Cultured Cells of Human Gynecological Cancers
- Is laser conization adequate for therapeutic excision of adenocarcinoma in situ of the uterine cervix?
- Frequent Integration of Human Papillomavirus 16 in Cervical Neoplasia(Oncology 6)
- Gonadotropin-Releasing Hormone Analogue Therapy for Peritoneal Inclusion Cysts after Gynecological Surgery
- Biological Characteristics of Human Uterine Endometrial Cancer Variant Cells Selected for Blood Group H Type 1 Antigen : Adhesion to Vascular Endothelial Cells
- Biological Function of Type1 Carbohydrate Antigen in Endometrial Cancer
- Selection of Human Ovarian Carcinoma Cells with High Dissemination Potential by Repeated Passage of the Cells in vivo into Nude Mice, and Involvement of Le^x-determinant in the Dissemination Potential
- Alteration of acidic lipids in human sera during the course of pregnancy : characteristic increase in the concentration of cholesterol sulfate
- High Expression of Uridine Diphosphate-galactose: Lc_3Cer β1-3 Galactosyltransferase in Human Uterine Endometrial Cancer-derived Cells as Measured by Enzyme-linked Immunosorbent Assay and Thin-layer Chromatography-immunostaining
- Enzymatic Basis for the Accumulation of Lewis^b Antigen Uterine in Endometrial Cancer
- Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line
- Association of Common LH Variant with Hyperfunctional Promoter in a Japanese Infertile Woman
- Characterization of novel glycolipid antigens with an α-galactose epitope in lactobacilli detected with rabbit anti-Lactobacillus antisera and occurrence of antibodies against them in human sera
- Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer